Explore

Trendline Trendline
Gilead Sciences Implements Major Workforce Reductions at Arcellx Following Acquisition

Gilead Sciences Implements Major Workforce Reductions at Arcellx Following Acquisition

Gilead Sciences Implements Major Workforce Reductions at Arcellx Following Acquisition
Trendline Trendline
Scholar Rock Advances Apitegromab for SMA with FDA Approval Milestone

Scholar Rock Advances Apitegromab for SMA with FDA Approval Milestone

Scholar Rock Advances Apitegromab for SMA with FDA Approval Milestone
Trendline Trendline
Whoop Introduces On-Demand Clinician Access for U.S. Users with New Health Features

Whoop Introduces On-Demand Clinician Access for U.S. Users with New Health Features

Whoop Introduces On-Demand Clinician Access for U.S. Users with New Health Features
Trendline Trendline
Rznomics Receives FDA RMAT Designation for RZ-001 in Liver Cancer Treatment

Rznomics Receives FDA RMAT Designation for RZ-001 in Liver Cancer Treatment

Rznomics Receives FDA RMAT Designation for RZ-001 in Liver Cancer Treatment
Trendline Trendline
Verastem Oncology Reports $18.7 Million Revenue in Q1 2026 Amid New Clinical Trials

Verastem Oncology Reports $18.7 Million Revenue in Q1 2026 Amid New Clinical Trials

Verastem Oncology Reports $18.7 Million Revenue in Q1 2026 Amid New Clinical Trials
Trendline Trendline
Harbour BioMed Receives FDA Clearance for HBM7004 to Treat Advanced Solid Tumors

Harbour BioMed Receives FDA Clearance for HBM7004 to Treat Advanced Solid Tumors

Harbour BioMed Receives FDA Clearance for HBM7004 to Treat Advanced Solid Tumors
Trendline Trendline
Incyte Releases Positive Long-Term Data for Opzelura Cream in Atopic Dermatitis Treatment

Incyte Releases Positive Long-Term Data for Opzelura Cream in Atopic Dermatitis Treatment

Incyte Releases Positive Long-Term Data for Opzelura Cream in Atopic Dermatitis Treatment
Trendline Trendline
Intellia Therapeutics Advances CRISPR Gene Editing with FDA Application for Hereditary Angioedema Treatment

Intellia Therapeutics Advances CRISPR Gene Editing with FDA Application for Hereditary Angioedema Treatment

Intellia Therapeutics Advances CRISPR Gene Editing with FDA Application for Hereditary Angioedema Treatment
Trendline Trendline
enVVeno Medical Advances enVVe System with FDA IDE Approval for Pivotal Study

enVVeno Medical Advances enVVe System with FDA IDE Approval for Pivotal Study

enVVeno Medical Advances enVVe System with FDA IDE Approval for Pivotal Study
Trendline Trendline
Rznomics Secures FDA RMAT Designation for RZ-001 in Hepatocellular Carcinoma Treatment

Rznomics Secures FDA RMAT Designation for RZ-001 in Hepatocellular Carcinoma Treatment

Rznomics Secures FDA RMAT Designation for RZ-001 in Hepatocellular Carcinoma Treatment
Trendline Trendline
RIVANNA Secures FDA Clearance for Accuro XV Ultrasound System, Enhancing Musculoskeletal Imaging

RIVANNA Secures FDA Clearance for Accuro XV Ultrasound System, Enhancing Musculoskeletal Imaging

RIVANNA Secures FDA Clearance for Accuro XV Ultrasound System, Enhancing Musculoskeletal Imaging
Trendline Trendline
Whoop to Introduce On-Demand Clinician Access for U.S. Users with New Features

Whoop to Introduce On-Demand Clinician Access for U.S. Users with New Features

Whoop to Introduce On-Demand Clinician Access for U.S. Users with New Features